Caribou Biosciences, Inc. CRBU
Set alert
0.44 USD +0.02 +3.95%
At close · Nov 2
0.43 -0.01 -1.55%
After hours · Nov 2, 6:22 PM ET
0.41 Day range 0.4498
0.423 52-week range 2.43
- YTD
- -72.33%
- 1 year
- -81.82%
- Open
- 0.4346
- Prev close
- 0.4232
- Mkt cap
- 47.16M
- Vol
- 3.30M
- Avg vol
- 2.59M
- EPS
- -1.08
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.41
- High
- 0.4498
- Forward P/E
- -0.90
- Beta
- 2.26
- Short ratio
- 4.55
- Inst. own
- 62.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 2.08
- 200-d avg
- 2.67
- 1y target
- 12.50
5D chart
Signals (104)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 9:30 AM | 18 hours ago |
| SMA: Bullish | Oct 30, 3:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:00 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:00 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:50 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:30 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:40 AM | 3 days ago |
| RSI: Oversold | Oct 30, 11:40 AM | 3 days ago |
Newest 20 of 104.
Analyst view
Consensus: none
Price target (mean) 12.50 +2741.6% upside
Now 0.4399
- Target (low)
- 3.00
- Target (mean)
- 12.50
- Target (high)
- 26.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
- Strong buy2
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.41804 | -0.47217 – -0.39 | -0.4091 | -2.2% | 1.84M | -48.2% | 4 |
| Next quarter | -0.44 | -0.44 – -0.44 | -0.4651 | +5.4% | 2.75M | +13.2% | 1 |
| Current year | -1.70 | -1.75 – -1.66 | -1.40 | -21.3% | 9.13M | -73.5% | 3 |
| Next year | -2.07 | -2.91 – -1.64 | -1.70 | -21.9% | 9.01M | -1.3% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 26, 2024 | Citigroup | Maintained | Buy | Buy |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 7, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Jul 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 4, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 16, 2024 | Truist Securities | Maintained | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 19, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 12, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Nov 8, 2023 | Cantor Fitzgerald | Initiated | — | Neutral |
| Jul 26, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 14, 2023 | Truist Securities | Reiterated | Buy | Buy |
| Jul 11, 2023 | Truist Securities | Initiated | — | Buy |
| May 10, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 14, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 10, 2023 | RBC Capital | Reiterated | — | Outperform |
| Mar 10, 2023 | Oppenheimer | Maintained | — | Outperform |
| Aug 29, 2022 | Citigroup | Maintained | — | Buy |
| Aug 18, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 10, 2022 | RBC Capital | Maintained | — | Outperform |
| May 13, 2022 | Citigroup | Maintained | — | Buy |
| May 12, 2022 | SVB Leerink | Maintained | — | Outperform |
| May 10, 2022 | SVB Leerink | Maintained | — | Outperform |
| Mar 22, 2022 | SVB Leerink | Maintained | — | Outperform |
| Feb 18, 2022 | RBC Capital | Initiated | — | Outperform |
| Feb 14, 2022 | Brookline Capital | Initiated | — | Buy |
| Dec 1, 2021 | Oppenheimer | Initiated | — | Outperform |
| Nov 30, 2021 | HC Wainwright & Co. | Initiated | — | Buy |